arrow
Back
C

Christophe Rochais

universite caen normandie

25H-index
126Paper Count
2.4KCitation Count
Published Papers 63
Publication Date
Structure-Guided Discovery of a Nonpeptidic MT5-MMP Inhibitor
err2026-05-25
err0
PREAI
errAntoine Magniez; Johanna Giovannini; Pauline Zipfel; Chloé Rémondin; Hassiba Saïdoun; Audrey Davis; Santiago Rivera; Patrick Dallemagne; Christophe Rochais; Alban Lepailleur
errShare
errSave
Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer’s Disease
err2026-04-13
err0
PREAI
errValentin Travers-Lesage; Marc Since; Alice Wang; Audrey Davis; Dimitri Fayolle; Benoit Bernay; Fabrice Modeste; Florian Nachon; Xavier Brazzalotto; Lucie Crouzier; Jana Sopkova-De Oliveira Santos; Tangui Maurice; Patrick Dallemagne; Christophe Rochais
errShare
errSave
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-based Therapy of Parkinson’s Disease
err2026-03-31
err0
errOAAI
errMireia Toledano-Pinedo; Alicia Porro-Pérez; Linda Schäker-Hübner; Daniel Diez-Iriepa; Isabel Iriepa; Agata Siwek; Małgorzata Wolak; Grzegorz Satała; Andrzej J. Bojarski; Agata Doroz-Płonka; Jadwiga Handzlik; Justyna Godyń; Patrick Dallemagne; Christophe Rochais; Audrey Davis; Marc Since; Belén Pérez; Aina Bellver-Sanchis; Alba Irisarri; Mercè Pallàs; Cristina Solana-Manrique; Francisco López-Muñoz; Lhassane Ismaili; Christian Griñán-Ferré; Nuria Paricio; Finn K. Hansen; Anna Więckowska; José Marco-Contelles
errShare
errSave
Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer’s disease model.
err2026-02-12
err0
PREAI
errValentin Travers--Lesage; Lucie Crouzier; Mirjana Antonijevic; Alice Wang; François-Xavier Toublet; Audrey Davis; Fabrice Modeste; Xavier Brazzolotto; Florian Nachon; Marc Since; Tangui Maurice; Christophe Rochais; Patrick Dallemagne
errShare
errSave
Targeting together cholinesterases and serotonin reuptake against Alzheimer's disease
err2025-06-01
err0
PREAI
errGuiselin, Thomas; Lecoutey, Cedric; Rochais, Christophe; Dallemagne, Patrick
errShare
errSave
Implication of Central β2 Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease
err2025-04-01
err0
errOAAI
errWang, Alice; Since, Marc; Dallemagne, Patrick; Rochais, Christophe
errShare
errSave
Anti-Breast Cancer Properties and In Vivo Safety Profile of a Bis-Carbazole Derivative
err2025-03-25
err0
errOAAI
errCeramella, Jessica; Rosano, Camillo; Iacopetta, Domenico; Ben Toumia, Imene; Chekir-Ghedira, Leila; Maatouk, Mouna; Mariconda, Annaluisa; Longo, Pasquale; Dallemagne, Patrick; Rochais, Christophe; Sinicropi, Maria Stefania
errShare
errSave
Evidence from a mouse model supports repurposing an anti-asthmatic drug, bambuterol, against Alzheimer's disease by administration through an intranasal route
err2025-02-01
err0
errOAAI
errGroo, Anne-Claire; Curel, Thomas; Malzert-Freon, Aurelie; Seguy, Line; Bento, Ophelie; Corvaisier, Sophie; Culerier, Thomas; Legrand, Romain; Callizot, Noelle; Henriques, Alexandre; Culley, Georgia; Claeysen, Sylvie; Rochais, Christophe; Dallemagne, Patrick
errShare
errSave
Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease
err2024-12-01
err0
errOAAI
errRochais, Christophe; Lecoutey, Cedric; Lalut, Julien; Davis, Audrey; Duval, Emilie; Gaven, Florence; Largilliere, Stacy; Nee, Gerald; Corvaisier, Sophie; Santos, Jana Sopkova de Oliveira; Since, Marc; Freret, Thomas; Legrand, Romain; Callizot, Noelle; Claeysen, Sylvie; Boulouard, Michel; Dallemagne, Patrick
errShare
errSave
Studies on the mechanisms of action of MR33317
err2024-06-10
err1
errOAAI
errNeumann, Joachim; Hesse, C.; Yahiaoui, S.; Dallemagne, P.; Rochais, C.; Hofmann, B.; Gergs, U.
errShare
errSave
Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy
err2024-05-16
err1
errOAAI
errMistretta, Maxime; Cimino, Mena; Campagne, Pascal; Volant, Stevenn; Kornobis, Etienne; Hebert, Olivier; Rochais, Christophe; Dallemagne, Patrick; Lecoutey, Cedric; Tisnerat, Camille; Lepailleur, Alban; Ayotte, Yann; LaPlante, Steven R.; Gangneux, Nicolas; Zahorszka, Monika; Kordulakova, Jana; Vichier-Guerre, Sophie; Bonhomme, Frederic; Pokorny, Laura; Albert, Marvin; Tinevez, Jean-Yves; Manina, Giulia
errShare
errSave
Synthesis and interest in medicinal chemistry of β-phenylalanine derivatives (β-PAD): an update (2010-2022)
err2024-05-09
err0
PREAI
errRemondin, Chloe; Mignani, Serge; Rochais, Christophe; Dallemagne, Patrick
errShare
errSave
Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents
err2024-01-19
err4
errOAAI
errAntonijevic, Mirjana; Charou, Despoina; Davis, Audrey; Curel, Thomas; Valcarcel, Maria; Ramos, Isbaal; Villace, Patricia; Claeysen, Sylvie; Dallemagne, Patrick; Gravanis, Achille; Charalampopoulos, Ioannis; Rochais, Christophe
errShare
errSave
Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer's Disease
err2023-09-26
err6
errOAAI
errGuiselin, Thomas; Lecoutey, Cedric; Rochais, Christophe; Dallemagne, Patrick
errShare
errSave
Design, synthesis and biological characterization of novel activators of the TrkB neurotrophin receptor
err2023-02-01
err5
errOAAI
errAntonijevic, Mirjana; Charou, Despoina; Ramos, Isbaal; Valcarcel, Maria; Gravanis, Achille; Villace, Patricia; Callizot, Noelle; Since, Marc; Dallemagne, Patrick; Charalampopoulos, Ioannis; Rochais, Christophe
errShare
errSave
C3-Symmetric Ligands in Drug Design: When the Target Controls the Aesthetics of the Drug
err2023-01-10
err7
errOAAI
errAntonijevic, Mirjana; Rochais, Christophe; Dallemagne, Patrick
errShare
errSave